CAS: 925206-65-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | RRX-001 REF: TM-T7400CAS: 925206-65-1 | 98.39% - ≥95% | 52.00 €~1,455.00 € | Tue 17 Dec 24 |
 | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one REF: 10-F517054CAS: 925206-65-1 | 95.0% | To inquire | Fri 20 Dec 24 |
 | RRx-001 REF: 3D-BR164811CAS: 925206-65-1 | Min. 95% | To inquire | Tue 21 Jan 25 |
 | RRX-001 REF: IN-DA00GU67CAS: 925206-65-1 | 95% | - - - | Discontinued product |
RRX-001
CAS:925206-65-1
RRx-001 is a potent inhibitor ofglucose 6-phosphate dehydrogenase(G6PD) and with potent antimalarial activity
Formula:
C5H6BrN3O5
Purity:
98.39% - ≥95%
Color and Shape:
Solid
Molecular weight:
268.02
Ref: TM-T7400
| 1mg | 52.00 € | ||
| 2mg | 76.00 € | ||
| 5mg | 113.00 € | ||
| 10mg | 150.00 € | ||
| 25mg | 274.00 € | ||
| 50mg | 477.00 € | ||
| 100mg | 695.00 € | ||
| 500mg | 1,455.00 € | ||
| 1mL*10mM (DMSO) | 126.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one
CAS:925206-65-1
Purity:
95.0%
Molecular weight:
268.02301025390625
Ref: 10-F517054
| 1g | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Friday 20 Dec 2024
RRx-001
CAS:925206-65-1
RRx-001 is a novel epigenetic modulator with potential radiosensitizing activity.
Purity:
Min. 95%
Ref: 3D-BR164811
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: IN-DA00GU67
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
